EORTC Brain Tumor Group: achievements and perspectives.
The EORTC Brain Tumor Group has a long standing history of achievements. The activities of the Brain Tumor Group have recently been re-structured in order to face the challenge of large intergroup/intercontinental trials and be a reference address for early drug development needed for gliomas. Constant adaptation to higher quality assurance criteria and implementation of translational research studies are now priorities for the Brain Tumor Group. Due to such activities, the EORTC Brain Group has become a major player in clinical research. The number of centres and patients joining its trials have greatly increased over the past 2 years. Achievements and strategies are detailed in this article.
Vecht
Ch J
ChJ
Neuro-oncology Unit, Department of Neurology, Medical Center Haaglanden/Westeinde, POB 432, 2501 CK, The Hague, The Netherlands. c.vecht@mchaaglanden.nl
van den Bent
M J
MJ
Lacombe
D
D
D000124:Achievement; D001932:Brain Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000379:methods; D005060:Europe; D006801:Humans; D007390:International Agencies / Q000458:organization & administration*; D007391:International Cooperation; D008495:Medical Oncology / Q000458:organization & administration*; D011785:Quality Assurance, Health Care; D012106:Research / Q000639:trends*; D012107:Research Design